CMC published fy q4 2007

1

Transcript of CMC published fy q4 2007

Page 1: CMC published fy q4 2007

Corporate Presentation Q4 FY 2006

Corporate Presentation Q4 FY 2006

LGIP Q4 FY 2012

LGIP Q4 FY 2012

Performance Analysis Q3 FY 2020 Q4 FY 2021

Performance Analysis Q3 FY 2020 Q4 FY 2021

Amplifon FY 2013 - Borsa Italiana...FY-2013 FY-2012 Q4-2013 Q4-2012 *Ebitdaadjtotakeintoaccountthe€4,1mlnone-offrestructuringcostsinFY2013 (€2,3mlninQ4) FY-2013 revenue was down

Amplifon FY 2013 - Borsa Italiana...FY-2013 FY-2012 Q4-2013 Q4-2012 *Ebitdaadjtotakeintoaccountthe€4,1mlnone-offrestructuringcostsinFY2013 (€2,3mlninQ4) FY-2013 revenue was down

Analyst Conference Call - Q4 FY 2015

Analyst Conference Call - Q4 FY 2015

Euronext Q4 & FY 2020 Results

Euronext Q4 & FY 2020 Results

CONDENSED FINANCIAL REPORT – SUPPLEMENTARY DATA · 2/73 Novartis Q4 and FY 2018 Condensed Financial Report – Supplementary Data Key figures Q4 2018 Q4 2017 % change FY 2018 FY

CONDENSED FINANCIAL REPORT – SUPPLEMENTARY DATA · 2/73 Novartis Q4 and FY 2018 Condensed Financial Report – Supplementary Data Key figures Q4 2018 Q4 2017 % change FY 2018 FY

20180523 TRNS Q4 FY18 Earnings Slides FINAL · 5/23/2018  · Q4 and Full Fiscal Year 2018 Execution Record revenue: Q4 up 10% to $42.5 million ... FY 2014 FY 2015 FY 2016 FY 2017

20180523 TRNS Q4 FY18 Earnings Slides FINAL · 5/23/2018  · Q4 and Full Fiscal Year 2018 Execution Record revenue: Q4 up 10% to $42.5 million ... FY 2014 FY 2015 FY 2016 FY 2017

Alma Media Q4 and FY 2014

Alma Media Q4 and FY 2014

Q4 and FY/2017 Preliminary Results Analyst and Investor ...€¦ · Summary Q4 and FY/2017 preliminary results presentation Q4 and FY/2017 Preliminary Results 21 February 2018 Deutsche

Q4 and FY/2017 Preliminary Results Analyst and Investor ...€¦ · Summary Q4 and FY/2017 preliminary results presentation Q4 and FY/2017 Preliminary Results 21 February 2018 Deutsche

Full$Year)and)Q4)2015)Results - AstraZeneca...2012 2013 FY"2014 FY"2015 Q4"2014 Q4"2015 Emerging)Markets Growth" rates"at" CER 2012 2013 FY"2014 FY"2015 Q4"2014 Q4"2015 China +4% +8%

Full$Year)and)Q4)2015)Results - AstraZeneca...2012 2013 FY"2014 FY"2015 Q4"2014 Q4"2015 Emerging)Markets Growth" rates"at" CER 2012 2013 FY"2014 FY"2015 Q4"2014 Q4"2015 China +4% +8%

Q4 fy 2016 earnings presentation final

Q4 fy 2016 earnings presentation final

PowerPoint Presentation€¦ · Life Insurance Period: FY2019 vs FY2018 20 9,038 8,868 3,233 1,994 181 3,054 FY-18 FY-19 Q4-FY18 Q3-FY19 Q4-FY19 483 474 104 160 FY-18 FY-19 Q4 ...

PowerPoint Presentation€¦ · Life Insurance Period: FY2019 vs FY2018 20 9,038 8,868 3,233 1,994 181 3,054 FY-18 FY-19 Q4-FY18 Q3-FY19 Q4-FY19 483 474 104 160 FY-18 FY-19 Q4 ...

Q1 FY2021 Earnings · 2020-06-02 · Q1 FY’19 Q2 FY’19 Q3 FY’19 Q4 FY’19 Q1 FY’20 Q2 FY’20 Q3 FY’20 Q4 FY’20 Q1 FY’21 Q2 FY’21 Guidance Quarterly subscription

Q1 FY2021 Earnings · 2020-06-02 · Q1 FY’19 Q2 FY’19 Q3 FY’19 Q4 FY’19 Q1 FY’20 Q2 FY’20 Q3 FY’20 Q4 FY’20 Q1 FY’21 Q2 FY’21 Guidance Quarterly subscription

Q4 & FY 2020 Review

Q4 & FY 2020 Review

Q4 AND FY 2014 RESULTS

Q4 AND FY 2014 RESULTS

Q4 & FY 2020-21

Q4 & FY 2020-21

GIL Q4 & FY 2012-13 Performance Update - Alpha Ideasalphaideas.in/.../2013/05/GIL-Q4-FY-2012-13-Performance-Update.pdf · 2 I Godrej Industries Limited I Q4 & FY 2012-13 | Performance

GIL Q4 & FY 2012-13 Performance Update - Alpha Ideasalphaideas.in/.../2013/05/GIL-Q4-FY-2012-13-Performance-Update.pdf · 2 I Godrej Industries Limited I Q4 & FY 2012-13 | Performance

PRELIMINARY RESULTS 4th QUARTER 2015/media/Files/S/Software-AG-IR/... · segment report q4 2015 / fy 2015 (in € m) Q4 2015 Q4 2014 ∆% ∆ % acc FY 2015 FY 2014 ∆ % ∆% acc

PRELIMINARY RESULTS 4th QUARTER 2015/media/Files/S/Software-AG-IR/... · segment report q4 2015 / fy 2015 (in € m) Q4 2015 Q4 2014 ∆% ∆ % acc FY 2015 FY 2014 ∆ % ∆% acc

FY 20 Consolidated Results ended March 31, 2020...2 PERFORMANCE OVERVIEW: Q4/ FY 20 (Consolidated) In ` crore Q4 FY 20 Q4 FY 19 Change (%) FY 20 FY 19 Change (%) Gross Revenue 1494.02

FY 20 Consolidated Results ended March 31, 2020...2 PERFORMANCE OVERVIEW: Q4/ FY 20 (Consolidated) In ` crore Q4 FY 20 Q4 FY 19 Change (%) FY 20 FY 19 Change (%) Gross Revenue 1494.02